Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Breast Cancer Research and Treatment
Published in: Breast Cancer Research and Treatment 1/1997

01-01-1997

Epidermal growth factor in plasma and saliva of patients with active breast cancer and breast cancer patients in follow-up compared with healthy women

Authors: Miguel A. Navarro, Ricard Mesía, Orland Díez-Gibert, Antonio Rueda, Belén Ojeda, María C. Alonso

Published in: Breast Cancer Research and Treatment | Issue 1/1997

Login to get access
Metadata
Title
Epidermal growth factor in plasma and saliva of patients with active breast cancer and breast cancer patients in follow-up compared with healthy women
Authors
Miguel A. Navarro
Ricard Mesía
Orland Díez-Gibert
Antonio Rueda
Belén Ojeda
María C. Alonso
Publication date
01-01-1997
Publisher
Kluwer Academic Publishers
Published in
Breast Cancer Research and Treatment / Issue 1/1997
Print ISSN: 0167-6806
Electronic ISSN: 1573-7217
DOI
https://doi.org/10.1023/A:1005755928831

Other articles of this Issue 1/1997

Breast Cancer Research and Treatment 1/1997 Go to the issue

OriginalPaper

Influence of estrogen metabolism on proliferation of human breast cancer

OriginalPaper

Estrogen increases intracellular p26Bcl-2 to p21Bax ratios and inhibits taxol-induced apoptosis of human breast cancer MCF-7 cells

OriginalPaper

Tumor characteristics and survival of breast cancer patients in relation to premorbid diet and body size

OriginalPaper

Enhanced anti-proliferative activity of the combination of tamoxifen plus HER-2-neu antibody

OriginalPaper

Magnetic resonance galactography for a patient with nipple discharge

OriginalPaper

Comparative effects of 1,25(OH)2D3 and EB1089 on cell cycle kinetics and apoptosis in MCF-7 breast cancer cells
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits